Rivas Maria
SEC insider (Form 3/4/5 filer). CIK 0001755794. Director at Telix Pharmaceuticals Ltd (TLX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in SAN RAMON, CA.
Companies Rivas Maria has filed insider reports for
- Telix Pharmaceuticals Ltd (TLX): Director
- COOPER COMPANIES, INC. (COO): Director
Rivas Maria
CIK: 0001755794
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (40.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Apr 1, 2026COO
COOPER COMPANIES, INC.
ExerciseDirect3.3K shares- - Apr 1, 2026COO
COOPER COMPANIES, INC.
AwardDirectRestricted Stock Units
3.8K shares- - Dec 18, 2025COO
COOPER COMPANIES, INC.
PurchaseIndirect1K shares at avg. $82.13$82K - Apr 1, 2025COO
COOPER COMPANIES, INC.
ExerciseDirect2.7K shares- - Apr 1, 2025COO
COOPER COMPANIES, INC.
AwardDirectRestricted Stock Units
3.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 |  COO COOPER COMPANIES, INC. | Exercise | 3,322 | - | $0 | Direct |
| Apr 1, 2026 | COO COOPER COMPANIES, INC. | Award Restricted Stock Units | 3,779 | - | - | Direct |
| Dec 18, 2025 | COO COOPER COMPANIES, INC. | Purchase | 1,000 | $82.13 | $82,130 | Indirect |
| Apr 1, 2025 | COO COOPER COMPANIES, INC. | Exercise | 2,721 | - | - | Direct |
| Apr 1, 2025 | COO COOPER COMPANIES, INC. | Award Restricted Stock Units | 3,322 | - | - | Direct |
1-5 of 5 transactions